Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study.

Christian Hamm (1, 2, 3, 4) , Oliver Dörr (2, 5) , Jochen Woehrle (6) , Florian Krackhardt (7) , Hüseyin Ince (8) , Tobias Zeus (9) , Jacques Bergland (10) , Christophe Piot (11) , François Roubille (12, 13) , Ingolf Schult (14) , Dominic Allocco (15, 16) , Holger Nef (2, 17)

1 Kerckhoff-Klinik
2 Universität Giessen [Germany]
3 Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany
4 German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Bad Nauheim, Germany
5 German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Bad Nauheim, Germany
6 Universitatsklinikum, Ulm Germany
7 Charite Campus Virchow Klinikum, Universitatsmedizin Berlin Germany
8 Universitatsklinikum Rostock, Rostock Germany
9 Universitatsklinikum Dusseldorf, Dusseldorf Germany
10 Clinique Saint-Hilaire [Rouen]
11 Clinique du Millénaire - Oc Santé [Montpellier]
12 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
13 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
14 Hemoteq AG, Wurselen Germany
15 Boston Scientific
16 Boston Scientific Corporation
17 German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Bad Nauheim, Germany

Treatment of in-stent restenosis of coronary stents is challenging. The use of drug-coated balloons (DCB) is a promising technique to treat in-stent restenosis without adding another metal layer.

Domaines: Sciences du Vivant [q-bio]

Christian Hamm, Oliver Dörr, Jochen Woehrle, Florian Krackhardt, Hüseyin Ince, et al.. Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study.. EuroIntervention , 2019, ⟨10.4244/EIJ-D-19-00051⟩. ⟨hal-02374505⟩